All Stories

  1. Integrated Biodevice for Parallel Magnetic Isolation and Bioelectrocatalytic Detection of Circulating DNA and RNA Biomarkers in Non-Small Cell Lung Cancer Liquid Biopsy
  2. Controlling Nucleic Acid Affinity Interactions and Adsorption Dynamics on Electrode Material Surfaces for Biosensing Applications
  3. Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature
  4. Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework
  5. On-site amplification-free electrochemical detection of the plant pathogen Xylella fastidiosa via cathodic potential-induced DNA adsorption
  6. Challenges in the Development and Implementation of Point‐of‐Care Handheld qPCR Devices
  7. Preeclampsia Diagnostics and Therapeutics: Advances, Challenges, and Prospects in Nanoscale Exosome-Based Clinical Translation
  8. DEVELOPING A DECENTRALIZED LIQUID BIOPSY MOLECULAR DEVICE WITHIN A BIOSENSOR TECHNOLOGY CLINICAL VALIDATION FRAMEWORK
  9. PEARL-B: A HANDHELD DIAGNOSTIC DEVICE FOR POINT-OF-CARE EARLY ANALYSIS USING RAPID LOOP-MEDIATED ISOTHERMAL AMPLIFICATION FOR BREAST CANCER
  10. Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases
  11. Do I have prostate cancer? Why a simple PSA blood test alone won’t give you the answer
  12. Enhancing Electrochemical Biosensing of Circulating Nucleic Acids at the Electrode-Biomolecule-Electrolyte Interfaces
  13. Nanoarchitectonics of point-of-care diagnostics for sweat biomarkers analysis
  14. Clinically Boosting Cancer Molecular Targeted Radioligand Therapies with Innovative Nanomaterials
  15. Point-of-need mastitis pathogen biosensing in bovine milk: From academic sample preparation novelty to industry prototype field testing
  16. Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy
  17. Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries
  18. Multifunctional Hybrid Nanozymes for Magnetic Enrichment and Bioelectrocatalytic Sensing of Circulating Tumor RNA during Minimal Residual Disease Monitoring
  19. Point-of-Need Automated Bovine Milk Sample Preparation and Molecular Biosensing of Bacterial Mastitis Pathogens
  20. Nanophotonic immunoarray with electrochemically roughened surfaces for handheld detection of secreted PD-L1 to predict immuno-oncology efficacy
  21. Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
  22. Streptavidin-Modified Iron Oxide Hybrid Nanozymes for Magnetic Enrichment and Bioelectrocatalytic Sensing of Circulating Tumor RNA
  23. Tetraplex Immunophenotyping of Cell Surface Proteomes via Synthesized Plasmonic Nanotags and Portable Raman Spectroscopy
  24. Harnessing Gene Fusion-Derived Neoantigens for ‘Cold’ Breast and Prostate Tumor Immunotherapy
  25. Molecular locker probe enrichment of gene fusion variants from matched patient liquid biopsy specimens for magneto-bioelectrocatalytic nanosensing
  26. Progressing Antimicrobial Resistance Sensing Technologies across Human, Animal, and Environmental Health Domains
  27. Bioengineered Polymer Nanobeads for Isolation and Electrochemical Detection of Cancer Biomarkers
  28. Magnetic nanomaterial–based electrochemical biosensors for the detection of diverse circulating cancer biomarkers
  29. Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges
  30. Simultaneous BRAFV600E Protein and DNA Aberration Detection in Circulating Melanoma Cells Using an Integrated Multimolecular Sensor
  31. Nucleic Acid Hybridization‐Based Noise Suppression for Ultraselective Multiplexed Amplification of Mutant Variants
  32. Direct Enhanced Detection of Multiple Circulating Tumor DNA Variants in Unprocessed Plasma by Magnetic-Assisted Bioelectrocatalytic Cycling
  33. Multiomics: The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies (Adv. Funct. Mater. 37/2020)
  34. Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies
  35. Phosphoprotein Biosensors for Monitoring Pathological Protein Structural Changes
  36. The Role of Circulating Tumor DNA Testing in Breast Cancer Liquid Biopsies: Getting Ready for Prime Time
  37. The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies
  38. Native MicroRNA Targets Trigger Self‐Assembly of Nanozyme‐Patterned Hollowed Nanocuboids with Optimal Interparticle Gaps for Plasmonic‐Activated Cancer Detection
  39. Engineering State‐of‐the‐Art Plasmonic Nanomaterials for SERS‐Based Clinical Liquid Biopsy Applications
  40. Watching SERS glow for multiplex biomolecular analysis in the clinic: A review
  41. Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
  42. An integrated multi-molecular sensor for simultaneous BRAFV600E protein and DNA single point mutation detection in circulating tumour cells
  43. Single droplet detection of immune checkpoints on a multiplexed electrohydrodynamic biosensor
  44. Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
  45. A Sample-to-Targeted Gene Analysis Biochip for Nanofluidic Manipulation of Solid-Phase Circulating Tumor Nucleic Acid Amplification in Liquid Biopsies
  46. “Mix-to-Go” Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction
  47. Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction
  48. Adjustable Fluidic Nanomixing: Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing (Small 17/2018)
  49. Amplification-Free Multi-RNA-Type Profiling for Cancer Risk Stratification via Alternating Current Electrohydrodynamic Nanomixing
  50. An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cells
  51. Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay
  52. Interfacial Biosensing: Direct Biosensing of Biomolecules at the Bare Metal Interface
  53. DNA-directed assembly of copper nanoblocks with inbuilt fluorescent and electrochemical properties: Application in simultaneous amplification-free analysis of multiple RNA species
  54. High-speed biosensing strategy for non-invasive profiling of multiple cancer fusion genes in urine
  55. A nanoplasmonic label-free surface-enhanced Raman scattering strategy for non-invasive cancer genetic subtyping in patient samples
  56. Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop
  57. Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine
  58. Rapid and Sensitive Fusion Gene Detection in Prostate Cancer Urinary Specimens by Label-Free Surface-Enhanced Raman Scattering
  59. A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2:ERG gene fusion RNA
  60. Amplification-Free Detection of Gene Fusions in Prostate Cancer Urinary Samples Using mRNA–Gold Affinity Interactions
  61. Poly(A) Extensions of miRNAs for Amplification-Free Electrochemical Detection on Screen-Printed Gold Electrodes
  62. Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification
  63. DNA–bare gold affinity interactions: mechanism and applications in biosensing
  64. Microdevices for detecting locus-specific DNA methylation at CpG resolution
  65. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes
  66. μ-eLCR: a microfabricated device for electrochemical detection of DNA base changes in breast cancer cell lines
  67. Advancing Gene Fusion Detection towards Personalized Cancer Nanodiagnostics